MyAverix Finance MyAverix Finance

KQ · Healthcare

Vaxcell-Bio Therapeutics Co. Ltd (323990)

Biotechnology

Vaxcell-Bio Therapeutics Co. Ltd (323990) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 323990

P/E ratio
25.00

Vaxcell-Bio Therapeutics Co. Ltd (323990) — FAQ

What is 323990's P/E ratio?

The price-to-earnings (P/E) ratio for Vaxcell-Bio Therapeutics Co. Ltd (323990) is 25.00 (data as of 2026-05-24).

Does Vaxcell-Bio Therapeutics Co. Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Vaxcell-Bio Therapeutics Co. Ltd (323990). Check the MyAverix Finance app for the latest dividend data.

What sector is Vaxcell-Bio Therapeutics Co. Ltd in?

Vaxcell-Bio Therapeutics Co. Ltd (323990) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 323990 listed on?

323990 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play